Peer Review History
| Original SubmissionFebruary 13, 2024 |
|---|
|
PONE-D-24-05885 Analysis of a new negevirus-like sequence from Bemisia tabaci unveils a potential new taxon linking nelorpi- and centiviruses PLOS ONE Dear Dr. Quito-Avila, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Apr 20 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Rhys Harold Parry Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. ""In your Methods section, please provide additional information regarding the permits you obtained for the work. Please ensure you have included the full name of the authority that approved the field site access and, if no permits were required, a brief statement explaining why.""" 3. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript. 4. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Dear Dr Quito-Avila, Your manuscript has now been reviewed by two experts in the field. They both find the results of interest and recommend publication pending several minor modifications. Please meet or respond to the concerns raised in an outlined review document and submit a resubmission of your manuscript. Dr. Rhys Parry [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Analysis of a new negevirus-like sequence from Bemisia tabaci unveils a potential new taxon linking nelorpi- and centiviruses The paper by Quito-Avila and colleagues describes the identification of a novel nege-like virus (complete genome sequenced) in the whitefly Bemisia tabaci, an important agricultural pest. Viruses found in this species are of importance given the hosts agricultural association and evidence suggesting that insect specific viruses such as the nege-like viruses may inhibit alphavirus infection offering a potential method of controlling arthropod-borne pathogens. The authors provide an in-depth characterisation of this novel virus including phylogenetic and structural analyses of structural proteins. Overall, I have no major concerns about this study, the manuscript is well written, and the methods used are adequate. However, the following should be addressed before this manuscript is suitable for publication in PLoS One. Figure 3: The vertical gaps between branches are inconsistent, have tips been manually pruned from the trees or is this an artefact from collapsing branches? Furthermore, the scale bar across the trees is quite large. Please add to the figure legend what the scale bar represents (amino acid substitutions per site?). Please provide further information about the alignments - length, pairwise identity, etc- used to infer these trees. If possible, alignments should be made publicly available in a data repository like Github to enable reproducibility. Likewise, it would be great if structure of SP24 was made available. Methods: - Please clarify whether the RNA from the ten whiteflies was extracted individually before being pooled to form a single library. - The authors state that they filtered out host-associated contigs by performing BLASTn against the Bemisia tabaci genome. The exclusion criteria here is unclear, please clarify whether all hits to the B. tabaci genome excluded and the e-value cutoff used. Similarly, e-value should be specified when describing the BLASTx analysis, i.e., "Homology of remaining contigs was explored by BLASTx using the non-redundant protein database (as of August 2023)." - Minor point, the authors include versioning and citations for some software in the methods section but not for others. Please include this information for all software used. - Please describe how the primers used in the PCR were designed (e.g., based on the whitefly negevirus 1 sequence or on some other sequence). - Please specify how bootstrap support was calculated. Figure legends: - In Figure 4B, please clarify what is meant by largest and lowest identity. This should also be included as a label on the figure key. - S1 Fig. I don’t see any information on how contig abundance is calculated. If this is just the percentage of contigs assigned to each group, I would refer to it as such, rather than using the term "abundance." Regardless, please describe the method for you used for calculating this metric. - Panel D) seems to be missing in the Figure 2 caption text. Minor comments: - In the abstract the authors state that “Both viruses form a clade sharing a recent ancestor with the proposed nelorpivirus and centivirus taxa”. From my reading of the text, the authors are referring the most recent common ancestor of these two taxa. This should be specified as the current wording implies that these taxa diverged recently, a conclusion that is not supported by the data. - Line 122: “Most accessions selected through PSI-BLAST encompassed both RdRp and SP24.” This current wording makes it seem that RdRp and SP24 were found on the same sequence, whereas I assume the intended meaning is the following: For most nege/kitavirids identified through PSI-BLAST both the RdRp and SP24 sequences were found. - Line 167: Phyton 3 should be Python 3 - Throughout the manuscript and figures capitalisation and italicisation of viral groups is inconsistent. Please refer to the following guide: https://ictv.global/faqs Reviewer #2: Whitefly negevirus 1 is a fascinating novel virus identified in an agriculturally significant host and falls within an evolutionarily interesting clade. The authors describe this novel virus in detail genomically and phylogenetically. The phylogenies in this paper also appear to link Nelorpivirus and Centivirus, hopefully bringing us a step to formally ratifying these clades. The methodology is reproducible and well-described overall. I have generally minor comments and queries throughout the manuscript as well as some suggestions for figure edits that should improve the ease of interpretation for a reader. These are detailed in a line-by-line review uploaded as an attachment. Overall, this is a robust paper that is sure to be of interest to the readers of PLOS ONE, and will be particularly valuable to readers focused on arthropod-associated viruses or unique and divergent RNA virus clades. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Analysis of a new negevirus-like sequence from Bemisia tabaci unveils a potential new taxon linking nelorpi- and centiviruses PONE-D-24-05885R1 Dear Dr. Quito-Avila, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Rhys Harold Parry Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-24-05885R1 PLOS ONE Dear Dr. Quito-Avila, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Rhys Harold Parry Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .